Transcripts Orient EuroPharma Co., Ltd.

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
42 ^TWD	-0.12%		+0.72%	+7.97%

05-20	Orient Europharma Co., Ltd. Signs an Exclusive Sales and Marketing Agreement for the New AIDS Drug Trogarzo in Taiwan with Taimed Biologics	CI
04-05	Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	CI

No results for this search